(Q37209821)

English

Colorectal cancer in relation to postmenopausal estrogen and estrogen plus progestin in the Women's Health Initiative clinical trial and observational study

scientific article published on May 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 August 2017

Colorectal cancer in relation to postmenopausal estrogen and estrogen plus progestin in the Women's Health Initiative clinical trial and observational study (English)

1 reference

Europe PubMed Central

19 August 2017

colorectal cancer

1 reference

based on heuristic

inferred from title

colorectal carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Jean Wactawski-Wende

4

object named as

Jean Wactawski-Wende

1 reference

Europe PubMed Central

19 August 2017

Shirley A A Beresford

3

object named as

Shirley A A Beresford

1 reference

Europe PubMed Central

19 August 2017

Marcia L. Stefanick

6

object named as

Marcia L Stefanick

1 reference

Europe PubMed Central

19 August 2017

Rowan T Chlebowski

7

object named as

Rowan T Chlebowski

1 reference

Europe PubMed Central

19 August 2017

F Allan Hubbell

5

object named as

F Allan Hubbell

1 reference

Europe PubMed Central

19 August 2017

author name string

Ross L Prentice

1

1 reference

Europe PubMed Central

19 August 2017

Mary Pettinger

2

1 reference

Europe PubMed Central

19 August 2017

publication date

1 May 2009

1 reference

Europe PubMed Central

19 August 2017

Cancer Epidemiology, Biomarkers & Prevention

1 reference

Europe PubMed Central

19 August 2017

18

1 reference

Europe PubMed Central

19 August 2017

5

1 reference

Europe PubMed Central

19 August 2017

1531-1537

1 reference

Europe PubMed Central

19 August 2017

Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689377

6 September 2017

Conjugated equine estrogens and colorectal cancer incidence and survival: the Women's Health Initiative randomized clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689377

6 September 2017

Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689377

6 September 2017

Estrogen plus progestin therapy and breast cancer in recently postmenopausal women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689377

6 September 2017

The women's health initiative: lessons learned

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689377

6 September 2017

Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689377

6 September 2017

Monitoring the randomized trials of the Women's Health Initiative: the experience of the Data and Safety Monitoring Board

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689377

6 September 2017

Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689377

6 September 2017

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689377

6 September 2017

The women's health initiative observational study: baseline characteristics of participants and reliability of baseline measures

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689377

6 September 2017

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689377

6 September 2017

Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689377

6 September 2017

Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689377

6 September 2017

Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689377

3 September 2018

Estrogen plus progestin and colorectal cancer in postmenopausal women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689377

3 September 2018

A meta-analysis of hormone replacement therapy and colon cancer in women.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689377

3 September 2018

Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy--long-term follow-up of a Swedish cohort.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689377

3 September 2018

Estrogen Plus Progestin Use, Microsatellite Instability, and the Risk of Colorectal Cancer in Women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689377

4 December 2018

Chemoprevention of colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19423530

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcomes ascertainment and adjudication methods in the women's health initiative

1 reference

https://pubmed.ncbi.nlm.nih.gov/19423530

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estrogen affects post-menopausal women differently than estrogen plus progestin replacement therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19423530

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monitoring and reporting of the Women's Health Initiative randomized hormone therapy trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/19423530

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1158/1055-9965.EPI-08-1209

1 reference

Europe PubMed Central

19 August 2017

1 reference

Europe PubMed Central

19 August 2017

1 reference

Europe PubMed Central

19 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37209821&oldid=2157032558"